{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:49:46Z","timestamp":1780548586186,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spain\u2019s Home Office"},{"DOI":"10.13039\/100014440","name":"Ministry of Science, Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Galician Regional Government (Xunta de Galicia","award":["ED431C 2017\/05"],"award-info":[{"award-number":["ED431C 2017\/05"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jpba.2020.113779","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T11:06:00Z","timestamp":1605956760000},"page":"113779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["An analytical strategy for designer benzodiazepines and Z-hypnotics determination in plasma samples using ultra-high performance liquid chromatography\/tandem mass spectrometry after microextraction by packed sorbent"],"prefix":"10.1016","volume":"194","author":[{"given":"A.M.","family":"Ares-Fuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113779_bib0005","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2019), European Drug Report 2019: Trends and Developments, Publications Office of the European Union, Luxembourg 2019, pag 17, 34-36. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/11364\/20191724_TDAT19001ENN_PDF.pdf. (Accessed in June 2020)."},{"key":"10.1016\/j.jpba.2020.113779_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dta.2211","article-title":"The emergence of new psychoactive substances (NPS) benzodiazepines: a review","volume":"10","author":"Manchester","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2020.113779_bib0015","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1039\/C5AN00797F","article-title":"An overview of recent developments in the analytical detection of new psychoactive substances (NPSs)","volume":"140","author":"Smith","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2020.113779_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/dta.2226","article-title":"Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances","volume":"10","author":"B\u00e4ckberg","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2020.113779_bib0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/bcpt.12684","article-title":"Long-term use of Z-hypnotics and co-medication with benzodiazepines and opioids","volume":"120","author":"Sakshaug","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2020.113779_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2014.09.018","article-title":"Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS\/MS","volume":"971","author":"Eliassen","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113779_bib0035","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/jssc.201700069","article-title":"Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography","volume":"40","author":"Tomkov\u00e1","year":"2017","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113779_bib0040","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jms.599","article-title":"Screening, library assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography\/mass spectrometry with atmospheric pressure chemical ionization","volume":"39","author":"Kratzsch","year":"2004","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113779_bib0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00414-017-1541-6","article-title":"Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer","volume":"131","author":"El Balkhi","year":"2017","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.jpba.2020.113779_bib0050","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00216-016-9439-6","article-title":"Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes","volume":"408","author":"Meyer","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113779_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of new designer benzodiazepines in forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2020.113779_bib0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","article-title":"Development and application of multi-component LC-MS\/MS method for determination of designer benzodiazepines in urine","volume":"1035","author":"Bergstrand","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113779_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.forsciint.2016.12.026","article-title":"Development and validation of a fast ionic liquid-based dispersive liquid-liquid microextraction procedure combined with LC-MS\/MS analysis for the quantification of benzodiazepines and benzodiazepines-like hypnotics in whole blood","volume":"274","author":"De Boeck","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2020.113779_bib0070","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1007\/s00216-018-1147-y","article-title":"Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS\/MS","volume":"410","author":"V\u00e5rdal","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113779_bib0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4155\/bio.15.48","article-title":"Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS\/MS","volume":"7","author":"Ambach","year":"2015","journal-title":"Bionalysis"},{"key":"10.1016\/j.jpba.2020.113779_bib0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jssc.201300784","article-title":"Development of an SPE method for the determination of zaleplon and zopiclone in hemolyzed blood using fast GC with negative-ion chemical ionization MS","volume":"37","author":"Karlonas","year":"2014","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113779_bib0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11094-015-1328-3","article-title":"Validation of a gas chromatography\/mass spectrometry method for quantitative determination of zolpidem in whole blood","volume":"48","author":"Krylova","year":"2015","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.jpba.2020.113779_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2017.04.008","article-title":"Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry","volume":"1053","author":"Meng","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113779_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.talanta.2017.08.010","article-title":"Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis-tandem mass spectrometry with successive multiple ionic-polymer layer coated capillary","volume":"176","author":"\u0160vidrnoch","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2020.113779_bib0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/00032710903492490","article-title":"Development of a liquid chromatographic method for the simultaneous determination of six benzodiazepines in human plasma after solid-phase extraction","volume":"43","author":"Fernandez","year":"2010","journal-title":"Anal. Lett."},{"key":"10.1016\/j.jpba.2020.113779_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.advms.2015.01.010","article-title":"Simultaneous analysis of zolpidem and its metabolite in whole blood and oral fluid samples by SPE-LC-MS\/MS for clinical and forensic purposes","volume":"60","author":"Piotrowski","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.jpba.2020.113779_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchromb.2003.11.042","article-title":"New trend in sample preparation: on-line microextraction in packed syringe for liquid and gas chromatography applications: I. Determination of local anesthetics in human plasma samples using gas chromatography-mass spectrometry","volume":"801","author":"Abdel-Rehim","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113779_bib0115","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1039\/C8AN02464B","article-title":"Current trends on microextraction by packed sorbent \u2013 fundamentals, application fields, innovative improvements and future applications","volume":"144","author":"Pereira","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2020.113779_bib0120","series-title":"Microextraction by Packed Sorbent (MEPS) and Monolithic Packed Pipette Tips for 96-well Plates in Solid-phase Extraction Handbooks in Separation Science","first-page":"473","author":"Moein","year":"2020"},{"key":"10.1016\/j.jpba.2020.113779_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.chroma.2017.01.021","article-title":"Analysis of drugs of abuse in human plasma using microextraction by packed sorbents and ultra-high-performance liquid chromatography","volume":"1485","author":"Fern\u00e1ndez","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113779_bib0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.talanta.2017.06.022","article-title":"A fast bioanalytical method based on microextraction by packed sorbent and UPLC\u2013MS\/MS for determining new psychoactive substances in oral fluid","volume":"174","author":"Ares","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2020.113779_bib0135","series-title":"Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry","author":"U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.jpba.2020.113779_bib0140","article-title":"ICH harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2 (R1)","year":"2005","journal-title":"International Conference of Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"key":"10.1016\/j.jpba.2020.113779_bib0145","doi-asserted-by":"crossref","first-page":"461241","DOI":"10.1016\/j.chroma.2020.461241","article-title":"Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography\u2014tandem mass spectrometry","volume":"1624","author":"da Cunha","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113779_bib0150","series-title":"CD-ROM. Ilustre Colegio Oficial de Qu\u00edmicos","article-title":"Tabla de concentraciones de xenobi\u00f3ticos en fluidos biol\u00f3gicos humanos como referencia para el diagn\u00f3stico toxicol\u00f3gico (versi\u00f3n 2015). Ampliaci\u00f3n de Toxicolog\u00eda de Postgrado 15","author":"Repetto","year":"2015"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520316654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520316654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:13:19Z","timestamp":1760001199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520316654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"alternative-id":["S0731708520316654"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113779","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An analytical strategy for designer benzodiazepines and Z-hypnotics determination in plasma samples using ultra-high performance liquid chromatography\/tandem mass spectrometry after microextraction by packed sorbent","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113779"}}